
Aim
To explore two main areas within breast cancer research. The first area is the identification of genetic determinants of non-BRCA1/2-linked familial breast cancer, with the second area being the search for novel biomarkers for diagnosis, prognosis, and prediction of therapy response of breast cancer. The ultimate goal of the program is to identify novel biomarkers for breast cancer that contribute to the improvement of patient survival in Qatar and the MENA region.
Scientific Coordinators

Dr. Nehad Alajez
Translational Oncology Research Center
Investigators

Dr. Julie Decock
Translational Oncology Research Center

Dr. Fares Al Ejeh
Translational Oncology Research Center

Dr. Mariam Al-Muftah
Translational Oncology Research Center

Dr. Khalid Ouararhni
HBKU Core Facilities

Dr. Abdelilah Arredouani
Diabetes Research Center(DRC)

Dr. Omar El Agnaf
Neurological Research Center (NDRC)

Dr. Houari Abdesselem
HBKU Core Facilities
Collaborators
Dr. Salahddin Gehani
Hamad Medical Corporation (HMC)
Dr. Salha Bujassoum
Hamad Medical Corporation (HMC)
Hikmat Abdel-Razaq
King Hussein Cancer Center (KHCC), Jordan
Dr. Omar Albagha
College of Health and Life Sciences (CHLS), HBKU